| 1996 | | Pharmacokinetic changes of methotrexate after intravenous administration to streptozotocin-induced diabetes mellitus rats. | 문창현 |
| 1996 | | Pharmacokinetic changes of methotrexate after intravenous administration to uranyl nitrate-induced acute renal failure rats. | 문창현 |
| 2019 | | Pharmacokinetic profile of propyl paraben in humans after oral administration | 이승호 |
| 2017 | | Pharmacokinetics and effect on the corrected QT interval of single-dose escitalopram in healthy elderly compared with younger adults | 김언혜 |
| 1998 | | Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus. | 문창현, 백은주, 이수환, 이희주, 정이숙 |
| 2015 | | Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein. | 손영배 |
| 2015 | | Pharmacologic Agents for Chronic Diarrhea. | 이광재 |
| 2020 | | Pharmacologic intervention for prevention of fractures in osteopenic and osteoporotic postmenopausal women: Systemic review and meta-analysis | 정윤석 |
| 2015 | | Pharmacologic treatment for inflammatory bowel disease | 이광재 |
| 2014 | | Pharmacological and nonpharmacological prevention of fentanyl-induced cough: a meta-analysis. | 김종엽, 문봉기, 민상기, 채윤정 |
| 1999 | | Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. | 이수환, 정이숙 |
| 2013 | | Pharmacological prevention of rocuronium-induced injection pain or withdrawal movements: a meta-analysis. | 김종엽, 문봉기, 민상기 |
| 2006 | | Pharmacological profile of KR-33028, a highly selective inhibitor of Na+/H+ exchanger. | 정이숙 |
| 2015 | | Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease. | 박주헌, 신승수 |
| 2021 | | Pharyngeal Airway Morphology in Skeletal Class III With Mandibular Asymmetry is Improved After Bimaxillary Orthognathic Surgery | 김영호, 신정원, 채화성 |
| 2013 | | Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). | 손영배 |
| 2019 | | Phase II randomized study of neoadjuvant metformin plus letrozole versus placebo plus letrozole for ER-positive postmenopausal breast cancer [METEOR Study] | 정용식 |
| 2014 | | Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR). | 정용식 |
| 2022 | | Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy | 권민석 |
| 2021 | | Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study) | 강석윤 |
